Skip to main content

Table 1 Comparison of baseline characteristics of participants and traditional cardiovascular risk factors across Fasa and Shahedieh cohort studies 2015–2016

From: Association between chronic kidney disease and cardiovascular disease risk factors in elderly: results from the first phase of Fasa and Shahedieh cohort studies

Variables

Fasa

Shahedieh

P value

Age (years) mean ± SD

63.7 ± 2.9

64.1 ± 3.1

˂ 0.001*

Gender

   

 Male, n (%)

660(44.4)

793(52.8)

˂ 0.001**

 Female, n (%)

827(55.6)

708(47.2)

 

Education level

  

˂ 0.001**

 Illiterate

1242(83.5)

821(54.5)

 

 1–5 years of school

218(14.7)

425(28.2)

 

 6–12 years of school

23(1.5)

181(12.0)

 

 University

4(0.3)

80(5.3)

 

Marital status

  

˂ 0.001**

 Single

6(0.4)

0(0)

 

 Married

1226(82.4)

1358(90.1)

 

 Widow

244(16.4)

147(9.7)

 

 Divorced

11(0.7)

2(0.1)

 

Socio-economic status

   

 Good

17(1.1)

47(3.1)

˂ 0.001**

 Average

575(38.7)

1183(78.5)

 

 Poor

895(60.2)

277(18.4)

 

MET

   

 Low(˂ 3), n (%)

112(7.5)

35(2.3)

˂ 0.001**

 Medium [3,4,5,6], n (%)

1279(86.0)

1448(96.5)

 

 Heavy(˃6), n (%)

96(6.5)

18(1.2)

 

BMI

   

 Underweight(˂19),n (%)

101(6.8)

18(1.2)

˂ 0.001**

 Appropriate [19,20,21,22,23,24,25], n (%)

670(45.2)

315(21.0)

 

 Overweight [25,26,27,28,29,30], n (%)

513(34.6)

635(42.4)

 

 Obesity(˃30), n (%)

197(13.3)

529(35.3)

 

BP (mm Hg), mean ± SD

   

 Systolic BP

122.4 ± 20.8

120.5 ± 17.6

0.006*

 Diastolic BP

78.0 ± 12.1

69.6 ± 9.9

˂ 0.001*

 Pulse Rate, min

74.3 ± 11.1

73.0 ± 9.4

0.001*

Individual habits (illicit drug, Cigarettes and alcohol)

   

 Smoking, n (%)

420(28.2)

362(24.0)

˂ 0.001**

 Opium Consumption, n (%)

211(14.2)

140(9.3)

˂ 0.001**

 Alcohol Consumption, n (%)

25(1.7)

47(3.1)

0.01**

Diseases

   

 Diabetes mellitus, n (%)

329(22.1)

553(36.8)

˂ 0.001**

 Hypertension, n (%)

653(43.9)

725(48.2)

0.01**

 Dyslipidemia, n (%)

597(40.1)

564(37.4)

0.1**

 Ischemic heart disease (IHD1), n (%)

364(24.5)

312(20.7)

0.01**

 Myocardial infarction, n (%)

59(4.0)

87(5.8)

0.02**

 Stroke, n (%)

50(3.4)

62(4.1)

0.2**

 Kidney failure (self-reported), n (%)

26(1.7)

27(1.8)

0.9**

Laboratory data

   

 Fasting blood sugar (FBS2), mmol/L

101.7 ± 37.2

121.9 ± 49.4

˂ 0.001**

 Total cholesterol, mmol/L

188.0 ± 42.0

190.9 ± 41.8

0.05**

 HDL3-cholesterol, mmol/L

51.9 ± 16.5

53.8 ± 12.1

˂ 0.001**

 LDL4-cholesterol, mmol/L

110.1 ± 35.3

103.8 ± 34.6

˂ 0.001**

 Triglycerides, mmol/L

129.7 ± 68.1

167.9 ± 88.6

˂ 0.001**

 BUN5

14.9 ± 4.4

32.7 ± 9.6

˂ 0.001**

 Creatinine

1.0 ± 0.2

1.1 ± 0.3

˂ 0.001**

eGFR

   

 CKD stage 1

86(5.8)

29(1.9)

˂ 0.001**

 CKD stage 2

1055(70.9)

567(37.6)

 

 CKD stage 3

341(22.9)

895(59.4)

 

 CKD stage 4 and 5

5(0.4)

16(1.1)

 
  1. * Independent Sample t test, ** Chi square test
  2. 1 Ischemic Heart Disease
  3. 2 Fasting Blood Sugar
  4. 3 High-Density Lipoprotein
  5. 4 Low-Density Lipoprotein
  6. 5 Blood Urea Nitrogen